Hypertension

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F18%3A10376636" target="_blank" >RIV/00216208:11110/18:10376636 - isvavai.cz</a>

Alternative codes found

RIV/00064190:_____/18:N0000026

Result on the web

<a href="https://doi.org/10.1038/nrdp.2018.14" target="_blank" >https://doi.org/10.1038/nrdp.2018.14</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1038/nrdp.2018.14" target="_blank" >10.1038/nrdp.2018.14</a>

Result language

angličtina

Original language name

Hypertension

Original language description

Systemic arterial hypertension is the most important modifiable risk factor for all-cause morbidity and mortality worldwide and is associated with an increased risk of cardiovascular disease (CVD). Fewer than half of those with hypertension are aware of their condition, and many others are aware but not treated or inadequately treated, although successful treatment of hypertension reduces the global burden of disease and mortality. The aetiology of hypertension involves the complex interplay of environmental and pathophysiological factors that affect multiple systems, as well as genetic predisposition. The evaluation of patients with hypertension includes accurate standardized blood pressure (BP) measurement, assessment of the patients&apos; predicted risk of atherosclerotic CVD and evidence of target-organ damage, and detection of secondary causes of hypertension and presence of comorbidities (such as CVD and kidney disease). Lifestyle changes, including dietary modifications and increased physical activity, are effective in lowering BP and preventing hypertension and its CVD sequelae. Pharmacological therapy is very effective in lowering BP and in preventing CVD outcomes in most patients; first-line antihypertensive medications include angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, dihydropyridine calcium-channel blockers and thiazide diuretics.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30201 - Cardiac and Cardiovascular systems

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2018

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Nature Reviews Disease Primers [online]

ISSN

2056-676X

e-ISSN

—

Volume of the periodical

4

Issue of the periodical within the volume

March

Country of publishing house

GB - UNITED KINGDOM

Number of pages

21

Pages from-to

—

UT code for WoS article

000428676700001

EID of the result in the Scopus database

2-s2.0-85044374070